Biocross

e4Risk

Biomarkers / Diagnostic
Central Nervous System
e4Risk is a non-genetic, cost effective, and highly reliable test to evaluate the risk to develop late onset Alzheimer’s Disease. The test detects the presence of the ApoE4 protein in human blood plasma using high-throughput chemical. The test is register
5Ready to Market, 4Register, 3Clinical validation, 2Preclinical Validation, 1R+D
Europe